explore -WSS

explore

author：entertainment 2025-09-06 06:16:52 - browse：6

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Dogs on Prozac: What pet anti

WSS

Study points to new risk in gene therapy death of Terry Horgan

With Roe v Wade overturned, abortion providers work to adapt

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

What we owe ALS patients — and why one company fell short

Health insurers' Q3 question: how much care are people getting?

UnitedHealth financials solid despite Change Healthcare cyberattack

focus

explore

entertainment

What does generative AI mean for health care? We asked experts

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Psychedelics group wrestles with new pharma identity

Some top drug companies are starting to take action on climate

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Setback for rare diseases as Taysha Gene Therapies pulls back

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Congress extends some pandemic preparedness programs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Flu, Covid vaccination rates decline, new survey data show

entertainment

What we owe ALS patients — and why one company fell short

More tobacco lobbyists active in statehouses

RSV injection headlines need to be accurate for good uptake

Health care needs a new profession: neuroimaging counseling

European officials brace for rough respiratory virus season

What we owe ALS patients — and why one company fell short

entertainment

hotspot

focus

entertainment